| Bioactivity | Rongliflozin (DJT1116PG) is a selective and orally active inhibitor of sodium-glucose co-transporter-2 (SGLT-2). Rongliflozin can be used for the research of type 2 diabetes mellitus (T2DM)[1]. |
| Name | Rongliflozin |
| CAS | 2648020-91-9 |
| Formula | C23H27ClO7.C5H7NO3.5/4H2O |
| Molar Mass | 602.55 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhang H, et al. Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium-glucose co-transporter-2, in people with type 2 diabetes mellitus. Diabetes Obes Metab. 2020 Feb;22(2):191-202. |
Rongliflozin
CAS: 2648020-91-9 F: C23H27ClO7.C5H7NO3.5/4H2O W: 602.55
Rongliflozin (DJT1116PG) is a selective and orally active inhibitor of sodium-glucose co-transporter-2 (SGLT-2). Ronglif
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.